Gene · 4057
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Familial Clustering and Genetic Analysis of Severe Thumb Carpometacarpal Joint Osteoarthritis in a Large Statewide Cohort. | J Hand Surg Am | 2022 | 36184273 | PubTator, text mining | PubMed |
| Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope. | Front Oncol | 2022 | 36158670 | PubTator, text mining | PubMed |
| An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas. | Diagn Pathol | 2022 | 36153549 | PubTator, text mining | PubMed |
| Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer. | Int J Biol Sci | 2022 | 36147464 | PubTator, text mining | PubMed |
| Recent Advances in Oral Peptide or Protein-Based Drug Liposomes. | Pharmaceuticals (Basel) | 2022 | 36145293 | PubTator, text mining | PubMed |
| Dendronized Gelatin-Mediated Synthesis of Gold Nanoparticles. | Molecules | 2022 | 36144835 | PubTator, text mining | PubMed |
| Neutrophil Activated by the Famous and Potent PMA (Phorbol Myristate Acetate). | Cells | 2022 | 36139464 | PubTator, text mining | PubMed |
| Identification of Unique Genetic Biomarkers of Various Subtypes of Glomerulonephritis Using Machine Learning and Deep Learning. | Biomolecules | 2022 | 36139115 | PubTator, text mining | PubMed |
| Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress. | Nat Immunol | 2022 | 36138183 | PubTator, text mining | PubMed |
| Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. | Cardiovasc Diabetol | 2022 | 36131342 | PubTator, text mining | PubMed |
| Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile. | PLoS One | 2022 | 36129958 | PubTator, text mining | PubMed |
| Bioselectivity of silk protein-based materials and their bio-inspired applications. | Beilstein J Nanotechnol | 2022 | 36127898 | PubTator, text mining | PubMed |
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. | Front Immunol | 2022 | 36110851 | PubTator, text mining | PubMed |
| Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ. | Front Genet | 2022 | 36105101 | PubTator, text mining | PubMed |
| Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer. | Cell Rep Med | 2022 | 36103879 | PubTator, text mining | PubMed |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. | J Clin Invest | 2022 | 36099049 | PubTator, text mining | PubMed |
| Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system. | PLoS One | 2022 | 36094909 | PubTator, text mining | PubMed |
| Gene-Based Network Analysis Reveals Prognostic Biomarkers Implicated in Diabetic Tubulointerstitial Injury. | Dis Markers | 2022 | 36092962 | PubTator, text mining | PubMed |
| A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration. | Front Genet | 2022 | 36092898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4057/papers?page=33